...
首页> 外文期刊>Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology >Prospective study evaluating performance of first-trimester combined screening for trisomy 21 using repeat sampling of maternal serum markers PAPP-A and free β-hCG.
【24h】

Prospective study evaluating performance of first-trimester combined screening for trisomy 21 using repeat sampling of maternal serum markers PAPP-A and free β-hCG.

机译:前瞻性研究评估的性能对于妊娠前三个月的联合筛查称21三体综合症使用重复抽样的孕产妇血清标记PAPP-A和自由βhcg。

获取原文
获取原文并翻译 | 示例
           

摘要

To prospectively evaluate the performance of first-trimester combined screening for trisomy 21 using the biochemical markers pregnancy-associated plasma protein-A (PAPP-A) and free beta-human chorionic gonadotropin (free β-hCG) obtained before and at the time of the nuchal translucency (NT) scan.Three fetal medicine departments in Denmark participated in the study. Screening for trisomy 21 was set up as a two-step approach with blood sampling performed before the NT scan (early sample) and again at the time of the NT scan (late sample). PAPP-A and free β-hCG were measured on both the early and late samples. Age-standardized detection and false-positive rates for different screening protocols were calculated.We collected two blood samples in 27 pregnancies affected by trisomy 21 and in 3891 control pregnancies. The early samples were taken between gestational ages 8 + 0 and 13 + 6 weeks, and the late samples between 11 + 3 and 14 + 6 weeks. The median interval between the samples was 17 (range, 1-40) days. We found a significantly better estimated screening performance when using early sampling vs late sampling (P < 0.05). With a risk cut-off of 1 in 100, at the time of the risk assessment the estimated detection and false-positive rates when using the early sample were 91% (95% CI, 81-98%) and 1.6% (95% CI, 1.3-2.0%), respectively. For fixed false-positive rates the highest detection rates were achieved using both blood samples. When comparing early sampling vs double sampling there was no significant difference in screening performance.In combined first-trimester screening for trisomy 21, use of early sampling with measurement of PAPP-A and free β-hCG before the time of the NT scan can optimize screening performance. Using maternal serum markers obtained both before and at the time of the NT scan has the potential to further improve performance, but larger studies are needed to confirm this potential. Copyright ? 2012 ISUOG. Published by John Wiley & Sons, Ltd.
机译:前瞻性评估的性能对于妊娠前三个月的联合筛查称21三体综合症使用生化标记乳素血浆蛋白质a (PAPP-A)和自由beta-human绒毛膜促性腺激素(免费βhcg)之前和时获得的颈背的半透明(NT)扫描。在丹麦医学部门参与这项研究。与血液采样进行两步方法在NT扫描(早期样本),再一次NT扫描的时间(晚样本)。免费βhcg测定在早期和末样品。假阳性率不同的筛选协议计算。样品在27个怀孕受称21三体综合症3891年,控制怀孕。采集标本之间妊娠年龄8 + 0和13 + 6周,后期样品之间的11+ 3和14 + 6周。样品17岁(第1 - 40范围)天。更好的估计筛选使用早期抽样与晚期时性能抽样(P < 0.05)。100年,当时的风险评估估计检测和假阳性时利率使用早期的样本是91% (95% CI, 81 - 98%)和1.6%(95%可信区间,1.3 - -2.0%),分别为。固定假阳性率最高的检测利率通过使用两个血液样本。当比较早期的采样vs双采样在筛选没有显著差异的性能。对于称21三体综合症,使用早期的抽样测量PAPP-A和自由β前hcgNT的扫描可以优化筛选的性能。获得之前和当时的NT扫描有可能进一步改善性能,但需要更大的研究证实了这种潜力。由约翰·威利出版& Sons,有限公司

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号